Germany’s Merck pumps up life sciences biz with $11.3B Bio-Techne deal Power Corridor 1d Merck KGaA Bio-Techne Pharma All sources
Merck to acquire Bio-Techne for $11.3bn, expanding bioprocessing and cell therapy capabilities Manufacturing Chemist 1d Mergers and Acquisitions Pharma Biotechnology
Merck Foundation, 12 African/Asia first ladies vow to improve healthcare delivery, capacity building ThisDay Live 7d Merck Foundation Pharma All sources